Back to all AI Solutions
AVIEW COPD
aview COPD automatically quantifies COPD with AI by performing pre-processing of segmentation of the lungs, lung lobes, and airway. Image biomarker for COPD such as emphysema, airway, vessel, fissure integrity are analyzed.
Healthcare benefits: Patient communication becomes easier with the automatically generated readings and reports.
Key benefits
- Concordance between radiologist and AI Emphysema 99% Airway 96%
- LAA (Low Attenuation Area) and LAA size analysis for emphysema
- 3D Visualization
Details
- Regulatory:
CE
FDA
CT
Lungs
Cardiology
- Clinical Applications:
CE
FDA
CT
Lungs
Cardiology
- Modality:
CE
FDA
CT
Lungs
Cardiology
- Body Part:
CE
FDA
CT
Lungs
Cardiology
Peer-reviewed publications
- Quantitative Computed Tomography Parameters in Coronavirus Disease 2019 Patients and Prediction of Respiratory Outcomes Using a Decision Tree. Read
- CT-Based Commercial Software Applications: Improving Patient Care Through Accurate COPD Subtyping. Read
- Quantitative assessment the longitudinal changes of pulmonary vascular counts in chronic obstructive pulmonary disease. Read
